
Trusted Development Partner to the Warfighter
In 2019, Med-Eng collaborated with the U.S. Department of War under a Cooperative Research and Development Agreement (CRADA) to develop the next generation Blast Tracker® technology.
Through trusted partnerships, our current personnel-borne blast dosimeter has undergone continuous improvements to develop the next generation Blast Tracker® technology system with accompanying software. These improvements have focused on:
-
- meeting evolving requirements and feedback from our end-users,
- incorporating new sensor technologies,
- integrating ongoing Research and Development, and
- mitigating unnecessary blast and noise exposure without degrading the quality of training or effectiveness of combat.

Blast Exposure Monitoring Program
Following a competitive, multi‑year development effort, Med‑Eng has been awarded a five‑year Indefinite Delivery/Indefinite Quantity (ID/IQ) contract with a maximum value of $50 million by the U.S. Department of War. Under the contract, Med‑Eng will deliver and support the Blast Exposure Monitoring (BEMO) Program — an integrated system of sensor hardware and software designed to measure and record blast overpressure exposure experienced by Warfighters during training as part of a broader brain health initiative.
The BEMO system enables military leaders and medical personnel to better monitor, evaluate, and respond to blast exposure events, supporting improved readiness and force safety. This award underscores Med‑Eng’s long‑standing expertise in explosive ordnance disposal technologies and its ability to translate advanced electronics and software into practical, mission‑critical solutions for the Warfighter.